Phase II study with gemcitabine in gallbladder and biliary tract carcinomas

Onkologie

Volumn 21, Issue 3, 1998, Pages 232-234

  Mezger, J ^a,c,d   Sauerbruch, T ^a   Ko, Y ^a   Wolter, H ^b   Funk, C ^a   Glasmacher, A ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Gemeinschaftspraxis Im Muhlenhof   (Germany)

^c Abt Medizin   (Germany)

^d Medizinische Abteilung II   (Germany)

Author keywords

Biliary tract carcinoma; Chemotherapy; Gallbladder carcinoma; Gemcitabine

Indexed keywords

FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; FATIGUE; FEMALE; FOLLOW UP; GALLBLADDER CARCINOMA; HUMAN; LEUKOPENIA; MALE; MUSCLE WEAKNESS; PHASE 2 CLINICAL TRIAL; THROMBOCYTOPENIA;

EID: 0031873767     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026821     Document Type: Article

References (11)

1. Pitt HA, Grochow LB, Abrams RA: Cancer of the biliary tree; in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer. Principles and Practice of Oncology. 5th ed Philadelphia, Lippincott-Raven, 1997, pp 1114-1127
2. Peters HD, Blatter J, Ermisch S: Gemcitabin. Pharmakologisches Profil und klinische Anwendung. Onkologe 1995;1:367-382.
3. Moore M: Activity of gemcitabine in patients with advanced pancreatic carcinoma. A review. Cancer 1996;78:633-638.
4. Burris HA, Moore MJ, Andersen J, Green M, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 1997;15: 2403-2407.
5. Hehenwarter W, Wein W, Schneider G, Reiter B, Pichler J, Lutz D: Gemcitabine in cholangiocarcinoma: Initially inoperable patient currently disease free (case report). Ann Oncol 1996; 7(suppl 5):248 (abstract).
6. UICC - International Union Against Cancer (Hermanek P, Scheibe O, Wagner G (Hrsg)): TNM - Klassifikation maligner Tumoren. 4th ed, 2nd revision Berlin, Springer, 1992.
7. Heinemann V, Wilke H, Possinger K, Mergenthaler K, Clemens M, Konig HJ, Illiger HJ, Blauer J, Schalhorn A, Fink U: Gemcitabine and cisplatin: Combination treatment for advanced pancreatic carcinoma. Proc Am Soc Clin Oncol 1996;15:246 (abstract)
8. Patt YZ, Jones DV, Hoque A, Lozano R, Markowitz A, Raijman I, Lynch P, Charnsangavej C: Phase II trial of intravenous fluorouracil and subcutaneous interferon alfa-2b for biliary tract cancer. J Clin Oncol 1996;14:2311-2315
9. Jones DV, Lozano R, Hoque A, Markowitz A, Patt YZ: Phase II study of pachtaxel therapy for unresectable biliary tree carcinomas. J Clin Oncol 1996;14: 2306-2310.
10. Sanz-Altamira PM, Huberman MS, Ferrante K, Stuart KE: Phase II study of 5-FU, Ieucovorin, and carboplatin in unresectable cholangiocarcinoma Proc Am Soc Clin Oncol 1996;15:219 (abstract).
11. Gebbia V, Majello E, Testa A, Pezzella G, Giuseppe S, Giotta F, Riccarcli F, Fortunato S, Colucci G, Gebbia N: Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxurea on a weekly schedule. Cancer 1996;78: 1300-1307.